Trulieve Cannabis Corp. (NYSE: TRLV) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $1.7B. The Maz Rating grades it against the other companies in its sector.
Trulieve Cannabis Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $10.07, Trulieve Cannabis Corp. trades at 1.6x sales and 2.5x book value. Over the last twelve months it generated about $1.1B of revenue and a net loss of $394M. It runs a gross margin of 60.6%, an operating margin of -25.3% and a net margin of -41.2%. It shows return on equity of -46.1%, return on invested capital of -13.4% and a free cash flow yield of 10.0%. On the balance sheet: a debt-to-equity ratio of 0.60 and a current ratio of 5.52. Over the past 52 weeks the share price ranged from $4.62 to $13.28, with a beta of 1.92.
Trulieve Cannabis Corp. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of September 2026, Trulieve Cannabis Corp. (TRLV) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 13.5% / 30% · (Cash+Inv) / Mkt Cap (36m) 22.1% / 30% · Interest income / Revenue 1.22% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 13.5% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 15.3% / 33% · Receivables / Mkt Cap (36m) 1.19% / 49% · Interest income / Revenue 1.22% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 13.5% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 15.3% / 33.33% · Receivables / Mkt Cap (24m) 1.19% / 33.33% · Interest income / Revenue 1.22% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 11.4% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 13.0% / 33.33% · Receivables / Avg Assets (4Q) 0.98% / 33.33% · Interest income / Revenue 1.22% / 5% | Pass |
| FTSE | Debt / Total Assets 13.6% / 33.33% · (Cash+ST Inv) / Total Assets 15.4% / 33.33% · (Cash+Recv) / Total Assets 16.6% / 33.33% · Interest income / Revenue 1.22% / 5% | Pass |
Yes. As of September 2026, Trulieve Cannabis Corp. (TRLV) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Trulieve Cannabis Corp. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 1.22% of each dividend: Trulieve Cannabis Corp.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.